Enter your keywords
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
Papers of the Week
The HBO Alzheimer's Project
My AlzForum Home
AlzRisk Paper Detail
Non-Steroidal Anti-Inflammatory Drugs
Average Follow-up Time Detail
The authors reported associations between fasting insulin and risk of AD separately for three strata of follow-up time, corresponding to:
-"short follow-up" (maximum of 3 years of follow-up from baseline),
-"medium follow-up" (3 to 5.5 years of follow-up from baseline), and
-"long follow-up" (5.5 to 9.7 years of follow-up from baseline)
This row of the table presents results obtained for individuals at risk of incident AD over the "medium follow-up" time frame.
Insulin levels were obtained from testing of thawed blood samples initially obtained approximately ten years previously, during an earlier wave of data collection in this cohort.
At baseline, the median insulin level was 9.3 mU/L, and the interquartile range was 6.6 mU/L to 13.3 mU/L.
Persons with a history of diabetes at baseline were excluded. History of diabetes was determined from self-reported use of diabetes medications/treatments, or from general practitioner or past Rotterdam cohort records indicative of a diabetes diagnosis.
"Fasting blood serum was drawn during the examination at the research center. The blood was stored at -80°C in a number of 5-mL aliquots. Glucose levels were measured within 1 week of sampling using the glucose hexokinase method.
The remaining serum was kept frozen for later analyses. In 2008, stored serum that had not been thawed previously was used for insulin measurements. Serum insulin was determined by metric assay (Biosource Diagnostics, Camarillo, CA)."
All participants were residents of a suburb of Rotterdam, The Netherlands. No other information on ethnicity or race has been reported.
Screening and Diagnosis Detail
Cambridge Examination for Mental Disorders of the Elderly
Geriatric Mental State Schedule (Copeland 1976)
Mini-Mental State Examination (Folstein 1975)
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Total dementia definition:
DSM-III-R used for total dementia.
"The diagnosis of dementia was made following a 3-step protocol.
Two brief tests of cognition (Mini- Mental State Examination
and Geriatric Mental State schedule
organic level) were used to screen all subjects. Participants with screen-positive results (Mini-Mental State Examination score <26 or Geriatric Mental State organic level >0) underwent the Cambridge Examination for Mental Disorders of the Elderly.
Subjects who were suspected of having dementia were, if necessary, examined by a neuropsychologist. In addition, the total cohort was continuously monitored for incident dementia through computerized linkage between the study database and digitized medical records from general practitioners and the Regional Institute for Outpatient Mental Health Care.
The diagnoses of dementia and AD were made in accordance with internationally accepted criteria for dementia (DSM-III-R),
and AD (National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association),
by a panel of a neurologist, neuropsychologist, and research physician."
Covariates & Analysis Detail
Cox proportional hazards regression
"We added a time-dependent covariate to the model to test the proportionality assumption. Because this assumption was violated, we performed the analyses in 3 different strata according to follow-up time: 1) short follow-up (maximum 3 years), 2) medium follow-up (3–5.5 years), and 3) long follow-up (5.5–9.7 years). Cutoffs were chosen to have approximately equal numbers of incident cases within the follow-up intervals."
This row of the table corresponds to the results obtained for 2881 subjects at risk of incident AD over the "medium follow-up" period.
APOE e4 genotype
diastolic blood pressure
systolic blood pressure